Changeflow GovPing Pharma & Drug Safety Patent Application: Acetic Acid and Hypochlorou...
Routine Notice Added Final

Patent Application: Acetic Acid and Hypochlorous Acid Compositions for Skin Trauma Treatment

Favicon for changeflow.com ChangeBridge: Patent Apps - Pharma (A61K)
Published September 22nd, 2025
Detected March 27th, 2026
Email

Summary

The USPTO has published a new patent application (US20260083774A1) detailing compositions containing hypochlorous acid and acetic acid for treating skin trauma and biofilms. The application was filed on September 22, 2025, and published on March 26, 2026.

What changed

The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260083774A1, concerning disinfecting compositions for treating skin trauma and biofilms. The application, filed on September 22, 2025, describes formulations containing hypochlorous acid and acetic acid, potentially in gel form or with controlled release mechanisms, for application to various tissue types.

This publication represents a new patent application and does not impose immediate regulatory obligations. However, it signals potential future developments in wound care and antimicrobial treatments. Companies involved in pharmaceutical manufacturing, medical device development, or healthcare provision should be aware of this patent filing as it may influence future product development and intellectual property landscapes in the treatment of skin trauma and infections.

Source document (simplified)

← USPTO Patent Applications

ACETIC ACID AND HYPOCHLOROUS ACID COMPOSITIONS FOR TREATMENT OF SKIN TRAUMA

Application US20260083774A1 Kind: A1 Mar 26, 2026

Inventors

Geir Hermod Almås

Abstract

Disinfecting compositions containing hypochlorous acid and acetic acid are useful for treating biofilms in or on tissue, including biofilms related to wounds or other skin trauma. The compositions are useful for treating a variety of types of tissue, both on the surface on beneath the surface of tissue. Compositions are provided having various concentrations for different tissue types and infection levels. Compositions may be provided in gel form, and may include nanoparticle encapsulated molecules for controlled release.

CPC Classifications

A61K 33/20 A61K 9/0014 A61K 31/19 A61K 33/42 C01B 11/04 A61K 2300/00

Filing Date

2025-09-22

Application No.

19335093

View original document →

Classification

Agency
USPTO
Published
September 22nd, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260083774A1

Who this affects

Applies to
Drug manufacturers Healthcare providers Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing 6211 Healthcare Providers
Activity scope
Drug Development Medical Device Development
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Medical Devices Public Health

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.